Long QT Syndrome Screening in Newborns

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 4000 participants.

Also called NCT02412709

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Phase 2
Enrolled
  • 4,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02412709
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02412709. Randomized; no masking; primary purpose screening. Start 2015-06 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Long QT Syndrome Screening in Newborns
Condition
Long QT Syndrome
Intervention (Device)
QTScreen ECG Recorder
Lead sponsor
QT Medical, Inc. (class: other)
Collaborator
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (class: other)
Collaborator
University of California, Irvine (class: other)

Record details

Record id
cardio:ct-nct02412709
Content hash
2a5a7accfc5e5353517321a7444791933176dae9dbed70d6b4a56b13cf042a94